HTFL — Heartflow, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1464521 ·
Last close
$25.23
Market Cap
$2.18B
52W High
$36.46
52W Low
$23.87
ADV30
1,791,896
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 52,587,000 | 42,164,000 | -22,022,000 | -27,380,000 | 344,025,000 | 19,671,000 | 58,307,000 |
| Dec 2025 | 49,130,000 | 39,063,000 | -17,750,000 | -24,395,000 | 359,452,000 | 44,776,000 | 58,805,000 |
| Sep 2025 | 46,276,000 | 35,415,000 | -15,099,000 | -50,855,000 | 364,398,000 | 291,167,000 | 109,830,000 |
| Jun 2025 | 43,424,000 | 32,778,000 | -13,715,000 | -9,196,000 | 159,363,000 | 80,210,000 | 1,054,158,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-70,961,000
Investing CF
$-238,894,000
Financing CF
$219,278,000
CapEx
$-5,813,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-1.76
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,115,130,000
Inventory
—
Receivables
$35,527,000
ST Investments
$138,645,000
EBIT TTM
$-101,796,000
Pretax Income TTM
$-111,879,000
Interest Exp TTM
$10,083,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$191,416,000
EBITDA
$-67,195,000
Free Cash Flow
$-48,654,124
Enterprise Value
$2,095,633,536
Total Cash
$158,316,000
Total Debt
$26,349,000
Shares Out
86,240,828
Trailing EPS
$-3.09
Book Value
$3.32
ROE
-135.3%
ROA
-16.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 176,034,000 | -64,066,000 | -116,791,000 | 359,452,000 | 58,805,000 | — | -54,023,000 |
| Dec 2024 | 125,808,000 | -61,222,000 | -96,426,000 | 118,704,000 | 978,188,000 | — | -69,001,000 |
| Dec 2023 | 87,174,000 | -72,914,000 | -95,655,000 | 185,051,000 | 962,615,000 | — | -76,434,000 |
TTM Snapshot
Revenues TTM
$32,934,000
NetIncome TTM
$-19,140,000
OpCashFlow TTM
$0
Assets (Latest)
$118,704,000
Forward EPS
$-0.27
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AXGN | Axogen, Inc. | $2.27B | $42.21 | — |
| LMAT | LEMAITRE VASCULAR INC | $2.32B | $101.32 | — |
| UFPT | UFP TECHNOLOGIES INC | $1.97B | $254.78 | — |
| PLSE | PULSE BIOSCIENCES, INC. | $2.43B | $35.13 | — |
| ATRC | AtriCure, Inc. | $1.92B | $37.76 | — |
News headlines (Yahoo Finance, 1h cache)
Roblox downgraded, Quanta Services upgraded: Wall Street's top analyst calls
2026-07-31 13:46 · Yahoo
Here Are Friday’s Top Wall Street Analyst Research Calls: Blackstone Mortgage, Boston Scientific, Edison International, Ford, GoDaddy, International Paper, Roblox, Saia, and More
2026-07-31 11:51 · Yahoo
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
2026-07-29 21:25 · Yahoo
Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026
2026-07-23 20:01 · Yahoo
Nvidia Returns to NZS Growth Fund
2026-07-21 12:22 · Yahoo
What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors?
2026-07-15 12:30 · Yahoo
New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management
2026-07-09 12:00 · Yahoo
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?
2026-07-08 21:41 · Yahoo
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
2026-07-04 14:04 · Yahoo
HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026?
2026-06-24 19:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.